Rigel Pharmaceuticals Inc (RIGL)
16.44
-0.71
(-4.14%)
USD |
NASDAQ |
Dec 24, 16:00
Rigel Pharmaceuticals Profit Margin (Quarterly): 22.46% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 3.10% |
| Return on Invested Capital | 12.00% |
| Gross Profit Margin (Quarterly) | 85.49% |
| Operating Margin (Quarterly) | 25.41% |
| Return on Net Operating Assets | 6.71% |